Pharmaceutical

GSK makes new drug submission for depemokimab in Canada

GSK has made a new drug submission (NDS) to Health Canada for the monoclonal antibody, depemokimab, targeting two specific conditions.

May 28, 2025 - 06:00
GSK makes new drug submission for depemokimab in Canada
GSK has made a new drug submission (NDS) to Health Canada for the monoclonal antibody, depemokimab, targeting two specific conditions.
Read the original article

Tags:

Previous Article

Capitalising on UK’s goal to become a world-leading clinical trial destination

Next Article

What’s been agreed at this year’s World Health Assembly?

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Purdue receives clearance for opioid overdose injector for younger individuals

Purdue receives clearance for opioid overdose injector ...

Aug 9, 2024

NHS launches “game-changer” and lifesaving anti-smoking pill

NHS launches “game-changer” and lifesaving anti-smoking...

Nov 13, 2024

Allakos cuts 75% of workforce after chronic hives trial failure 

Allakos cuts 75% of workforce after chronic hives trial...

Jan 30, 2025